The National Pharmaceutical Pricing Authority’s, (NPPA) on December 19, 2024, issued a notification regarding the addition to NPPA Ceiling Price Order for Scheduled Formulations.
An amendment to its Order No. 2286(E) dated 14th June 2024, concerning ceiling price fixation for scheduled formulations. As per the decision of the 128th Authority meeting, the following addition has been made to Table 'B':
Sl. No. 2: M/s Jedux Parenteral Private Limited - Product/Brand Name: JEDUX DOUBLE PORT WITH EURO HEAD, JPORT PLUS.
[Notification No. S.O. 5502(E)]